1. Academic Validation
  2. Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling

Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling

  • Cell. 2012 Aug 17;150(4):780-91. doi: 10.1016/j.cell.2012.06.037.
Fa-Xing Yu 1 Bin Zhao Nattapon Panupinthu Jenna L Jewell Ian Lian Lloyd H Wang Jiagang Zhao Haixin Yuan Karen Tumaneng Hairi Li Xiang-Dong Fu Gordon B Mills Kun-Liang Guan
Affiliations

Affiliation

  • 1 Department of Pharmacology and Moores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA.
Abstract

The Hippo pathway is crucial in organ size control, and its dysregulation contributes to tumorigenesis. However, upstream signals that regulate the mammalian Hippo pathway have remained elusive. Here, we report that the Hippo pathway is regulated by G-protein-coupled receptor (GPCR) signaling. Serum-borne lysophosphatidic acid (LPA) and sphingosine 1-phosphophate (S1P) act through G12/13-coupled receptors to inhibit the Hippo pathway kinases Lats1/2, thereby activating YAP and TAZ transcription coactivators, which are oncoproteins repressed by Lats1/2. YAP and TAZ are involved in LPA-induced gene expression, cell migration, and proliferation. In contrast, stimulation of Gs-coupled receptors by glucagon or epinephrine activates Lats1/2 kinase activity, thereby inhibiting YAP function. Thus, GPCR signaling can either activate or inhibit the Hippo-YAP pathway depending on the coupled G protein. Our study identifies extracellular diffusible signals that modulate the Hippo pathway and also establishes the Hippo-YAP pathway as a critical signaling branch downstream of GPCR.

Figures
Products
我们的 Cookie 政策

我们使用 Cookies 和类似技术以提高网站的性能和提升您的浏览体验,部分功能也使用 Cookies 帮助我们更好地理解您的需求,为您提供相关的服务。 如果您有任何关于我们如何处理您个人信息的疑问,请阅读我们的《隐私声明》